terça-feira, 22 de setembro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleCB Insights

CEO Interview: AIVI Technologies

View original at cbinsights.com
CB Insights - Enterprise Ai Title: CEO Interview: AIVI Technologies Date: 2026-08-31 22:00 Source: https://www.cbinsights.com/research/ceo-interview-aivi-technologies/ <h4><strong>Chao He, Founder & CEO at <a href="https://app.cbinsights.com/profiles/c/7K0wZ?tab=overview">AIVI</a>, tells CB Insights how they see Asia’s…
Opening lines of the source · CB Insights · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Asia's innovation ecosystem has drastically changed over the past decade, moving from being a fast-follower copying Western business models to Asia, particularly China, moving from consumer internet and app clones into hardcore deep tech.

    60% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,983
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,983 factos verificados com a fonte5,304 documentos-fonte arquivados
Consulte estes dados → isubstrate.com